Study Identifies Gene for Ovarian Cancer

NOVEMBER 01, 2005

An excess of the Rsf-1 gene may play an important role in the development of ovarian cancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotyping technique to identify "subchromosomal alterations," the researchers observed an overproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressive forms of ovarian cancer. These results were not seen in any of the low-grade ovarian cancers.

Because this was the first study to identify this genetic alteration, the new finding may lead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerous cell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings of the National Academy of Sciences (September 27, 2005).




SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.